A major contemporary review in The Lancet revisits sepsis as a syndrome driven by a dysregulated host response to infection that can vary widely between patients. The review emphasises that susceptibility to developing or dying from sepsis is influenced by pathogen and infection site, host biology, comorbidities, immunosuppression, age and environmental and social factors. That heterogeneity helps explain why interventions that appear biologically promising do not always produce uniform clinical benefit. It also supports the growing movement toward precision approaches, better phenotyping and context-aware treatment. The article brings together developments in definitions, recognition, organ dysfunction, infection management, supportive care and future research directions. For ICU clinicians, the practical message is to avoid assuming that a single pathway fits every patient. The same blood pressure target, fluid strategy, antimicrobial approach or adjunctive therapy may not have the same risk-benefit balance across different physiological states. The review also reinforces the importance of source control and timely organ support while recognising that treatment must evolve as the patient's phenotype changes. This paper fits CritiCARE's themes of personalised medicine, evolving sepsis definitions, data-driven care and the challenge of translating global evidence into practical ICU decisions. It is particularly useful as a high-level evidence map before diving into individual sepsis trials.